Cargando…

Substance use in people at clinical high-risk for psychosis

BACKGROUND: Some high-risk (HR) mental states for psychosis may lack diagnostic specificity and predictive value. Furthermore, psychotic-like experiences found in young populations may act not only as markers for psychosis but also for other non-psychotic psychiatric disorders. A neglected considera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russo, Debra A, Stochl, Jan, Painter, Michelle, Jones, Peter B, Perez, Jesus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299794/ https://www.ncbi.nlm.nih.gov/pubmed/25540036 http://dx.doi.org/10.1186/s12888-014-0361-1

Ejemplares similares

Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis()
por: Hui, Christy, et al.
Publicado: (2013)

Trauma history characteristics associated with mental states at clinical high risk for psychosis
por: Russo, Debra A., et al.
Publicado: (2014)

Use of the Theory of Planned Behaviour to assess factors influencing the identification of students at clinical high-risk for psychosis in 16+ Education
por: Russo, Debra A., et al.
Publicado: (2015)

34.3 IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF DEVELOPING PSYCHOSIS IN PRIMARY MENTAL HEALTH CARE
por: Perez, Jesus, et al.
Publicado: (2018)

Comparison of high and low intensity contact between secondary and primary care to detect people at ultra-high risk for psychosis: study protocol for a theory-based, cluster randomized controlled trial
por: Perez, Jesus, et al.
Publicado: (2013)

Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis
por: Perry, Benjamin I, et al.
Publicado: (2021)

Clinical effectiveness and cost-effectiveness of tailored intensive liaison between primary and secondary care to identify individuals at risk of a first psychotic illness (the LEGs study): a cluster-randomised controlled trial
por: Perez, Jesus, et al.
Publicado: (2015)

More sensitive identification of psychotic experiences in common mental disorder by primary mental healthcare services – effect on prevalence and recovery: casting the net wider – CORRIGENDUM
por: Knight, Clare, et al.
Publicado: (2021)

More sensitive identification of psychotic experiences in common mental disorder by primary mental healthcare services – effect on prevalence and recovery: casting the net wider
por: Knight, Clare, et al.
Publicado: (2020)

O3.6. PREVALENCE OF AND RECOVERY FROM COMMON MENTAL DISORDERS INCLUDING PSYCHOTIC EXPERIENCES
por: Perez, Jesus, et al.
Publicado: (2020)

An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis
por: Perry, B., et al.
Publicado: (2022)

Psychological interventions for people with psychotic experiences: A systematic review and meta-analysis of controlled and uncontrolled effectiveness and economic studies
por: Soneson, Emma, et al.
Publicado: (2020)

Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical Outcome
por: Hird, Emily J, et al.
Publicado: (2022)

Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults
por: Perry, Benjamin I., et al.
Publicado: (2021)

30.3 ASSOCIATION BETWEEN SERUM C-REACTIVE PROTEIN, POSITIVE AND NEGATIVE SYMPTOMS OF PSYCHOSIS IN A GENERAL POPULATION-BASED BIRTH COHORT
por: Khandaker, Golam, et al.
Publicado: (2018)

Emerging Temporal Lobe Dysfunction in People at Clinical High Risk for Psychosis
por: Allen, Paul, et al.
Publicado: (2019)

Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis
por: Davies, Cathy, et al.
Publicado: (2019)

The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis
por: Tognin, Stefania, et al.
Publicado: (2022)

Association between circulating levels of C-reactive protein and positive and negative symptoms of psychosis in adolescents in a general population birth cohort
por: Khandaker, Golam M., et al.
Publicado: (2021)

Perspective on clinical high-risk for psychosis in Africa
por: Awhangansi, Sewanu, et al.
Publicado: (2023)

Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis
por: Amir, Carolyn M., et al.
Publicado: (2023)

Psychosis and substance abuse increase the COVID-19 mortality risk
por: Catalan, Ana, et al.
Publicado: (2023)

Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis
por: Catalan, Ana, et al.
Publicado: (2022)

Editorial: Substance use and the psychosis spectrum
por: Kirli, Umut, et al.
Publicado: (2022)

Meta-analysis of longitudinal neurocognitive performance in people at clinical high-risk for psychosis
por: Hedges, Emily P., et al.
Publicado: (2022)

Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
por: Modinos, Gemma, et al.
Publicado: (2021)

Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
por: Allen, Paul, et al.
Publicado: (2021)

The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples
por: Perry, Benjamin I., et al.
Publicado: (2022)

Longitudinal association between CRP levels and risk of psychosis: a meta-analysis of population-based cohort studies
por: Osimo, Emanuele F., et al.
Publicado: (2021)

Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis
por: Mechelli, Andrea, et al.
Publicado: (2017)

Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis
por: Pollak, Thomas A., et al.
Publicado: (2020)

Correction: Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
por: Allen, Paul, et al.
Publicado: (2021)

Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis
por: Zhornitsky, Simon, et al.
Publicado: (2015)

Association of Childhood Infection With IQ and Adult Nonaffective Psychosis in Swedish Men: A Population-Based Longitudinal Cohort and Co-relative Study
por: Khandaker, Golam M., et al.
Publicado: (2018)

Correlates of substance use in a large naturalistic cohort of young people with early and emerging psychosis
por: El-Hage, D., et al.
Publicado: (2023)

Natural Language Processing markers in first episode psychosis and people at clinical high-risk
por: Morgan, Sarah E., et al.
Publicado: (2021)

Time‐course of clinical symptoms in young people at ultra‐high risk for transition to psychosis
por: Meneghelli, Anna, et al.
Publicado: (2021)

Formal thought disorder in people at ultra-high risk of psychosis
por: Demjaha, Arsime, et al.
Publicado: (2017)

Psychological interventions for people with psychotic experiences: protocol for a systematic review and meta-analysis
por: Soneson, Emma, et al.
Publicado: (2019)

Capgras syndrome in substance-induced psychosis
por: Sampathi, Bharat R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_isk09g5mf3b4nk263f56tht4rl